1. ZHAW digitalcollection
  2. Life Sciences und Facility Management
  3. Publikationen
  4. Publikationen Life Sciences und Facility Management
Full metadata record
DC FieldValueLanguage
dc.contributor.authorChellat, Mathieu F.-
dc.contributor.authorRiedl, Rainer-
dc.date.accessioned2018-02-20T16:04:19Z-
dc.date.available2018-02-20T16:04:19Z-
dc.date.issued2017-
dc.identifier.issn1433-7851de_CH
dc.identifier.issn0570-0833de_CH
dc.identifier.urihttps://digitalcollection.zhaw.ch/handle/11475/2881-
dc.description.abstractSeek, and ye shall find: After years of focusing research on synthetic antibiotics out of fear that all the useful natural ones had already been found, a novel antibacterial compound has been discovered through conventional microbial extract screening. The broad-spectrum nucleoside-analogue inhibitor pseudouridimycin is selective for bacterial RNA polymerase and elicits very low resistance rates.de_CH
dc.language.isoende_CH
dc.publisherWileyde_CH
dc.relation.ispartofAngewandte Chemie: International Editionde_CH
dc.rightsLicence according to publishing contractde_CH
dc.subjectRNA polymerasede_CH
dc.subjectAntibioticsde_CH
dc.subjectMedicinal chemistryde_CH
dc.subjectNatural productsde_CH
dc.subjectNucleoside analoguesde_CH
dc.subject.ddc615: Pharmakologie und Therapeutikde_CH
dc.titlePseudouridimycin : the first nucleoside analogue that selectively inhibits bacterial RNA polymerasede_CH
dc.typeBeitrag in wissenschaftlicher Zeitschriftde_CH
dcterms.typeTextde_CH
zhaw.departementLife Sciences und Facility Managementde_CH
dc.identifier.doi10.1002/anie.201708133de_CH
dc.identifier.pmid28895263de_CH
zhaw.funding.euNode_CH
zhaw.issue43de_CH
zhaw.originated.zhawYesde_CH
zhaw.pages.end13186de_CH
zhaw.pages.start13184de_CH
zhaw.publication.statuspublishedVersionde_CH
zhaw.volume56de_CH
zhaw.publication.reviewPeer review (Publikation)de_CH
zhaw.webfeedCC Drug Discoveryde_CH
Appears in collections:Publikationen Life Sciences und Facility Management

Files in This Item:
There are no files associated with this item.
Show simple item record
Chellat, M. F., & Riedl, R. (2017). Pseudouridimycin : the first nucleoside analogue that selectively inhibits bacterial RNA polymerase. Angewandte Chemie: International Edition, 56(43), 13184–13186. https://doi.org/10.1002/anie.201708133
Chellat, M.F. and Riedl, R. (2017) ‘Pseudouridimycin : the first nucleoside analogue that selectively inhibits bacterial RNA polymerase’, Angewandte Chemie: International Edition, 56(43), pp. 13184–13186. Available at: https://doi.org/10.1002/anie.201708133.
M. F. Chellat and R. Riedl, “Pseudouridimycin : the first nucleoside analogue that selectively inhibits bacterial RNA polymerase,” Angewandte Chemie: International Edition, vol. 56, no. 43, pp. 13184–13186, 2017, doi: 10.1002/anie.201708133.
CHELLAT, Mathieu F. und Rainer RIEDL, 2017. Pseudouridimycin : the first nucleoside analogue that selectively inhibits bacterial RNA polymerase. Angewandte Chemie: International Edition. 2017. Bd. 56, Nr. 43, S. 13184–13186. DOI 10.1002/anie.201708133
Chellat, Mathieu F., and Rainer Riedl. 2017. “Pseudouridimycin : The First Nucleoside Analogue That Selectively Inhibits Bacterial RNA Polymerase.” Angewandte Chemie: International Edition 56 (43): 13184–86. https://doi.org/10.1002/anie.201708133.
Chellat, Mathieu F., and Rainer Riedl. “Pseudouridimycin : The First Nucleoside Analogue That Selectively Inhibits Bacterial RNA Polymerase.” Angewandte Chemie: International Edition, vol. 56, no. 43, 2017, pp. 13184–86, https://doi.org/10.1002/anie.201708133.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.